HK Stock Market Move | JIANGXI BIO (06915) Falls Over 14%; Share Price Has Retreated More Than 70% from September High; First-Half R&D Expenditure Increased

JIANGXI BIO (06915) fell over 14%. Notably, the stock has retreated more than 70% from its September high. As of press time, it was down 14.26% at HK$5.86, with turnover of HK$1.193 million. On the news front, JIANGXI BIO previously disclosed its interim results. In the first half of 2026, the company's revenue was RMB83.3 million, down about 16.5% year on year; R&D expenditure was RMB11 million, up 18.6% year on year; net profit was RMB14.366 million, down 61% year on year; adjusted net profit, excluding one-off items such as listing expenses and tax rate differentials, was about RMB38.7 million, down 21.7% year on year. The company said the changes in results were mainly attributable to increased R&D expenditure; adjustments to relevant national tax policies; lower investment income; increased depreciation of fixed assets; and one-off listing expenses.